# Noninvasive Markers of Functional Nausea in Children

> **NCT03593811** · EARLY_PHASE1 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Nausea

## Interventions

- **DIAGNOSTIC_TEST:** Questionnaires
- **DIAGNOSTIC_TEST:** 4 channel electrogastrogram (EGG)
- **DIAGNOSTIC_TEST:** 36 channel high resolution electrogastrogram (HR-EGG)
- **DIAGNOSTIC_TEST:** Magnetogastrogram (MGG)
- **DIAGNOSTIC_TEST:** Electrocardiogram (EKG)
- **DRUG:** Ondansetron
- **DRUG:** Cyproheptadine Oral Tablet

## Key facts

- **NCT ID:** NCT03593811
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-03
- **Primary completion:** 2021-04-02
- **Final completion:** 2021-04-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03593811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03593811, "Noninvasive Markers of Functional Nausea in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03593811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*